| ²é¿´: 243 | »Ø¸´: 2 | ||||
haoyumomoÒø³æ (СÓÐÃûÆø)
|
[ÇóÖú]
άÆÕÇóÖú ÒÑÓÐ2È˲ÎÓë
|
| 14.57,47,49.7,70.1,132.6,138.4,151.9 |
» ²ÂÄãϲ»¶
336Çóµ÷¼Á£¬Ò»Ö¾Ô¸Öпƴó
ÒѾÓÐ6È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
071000ÉúÎïѧ£¬Ò»Ö¾Ô¸ÉîÛÚ´óѧ296·Ö£¬Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤085600 310·ÖÇóµ÷¼Á
ÒѾÓÐ19È˻ظ´
274Çóµ÷¼ÁÇóµ÷¼Á
ÒѾÓÐ7È˻ظ´
277¹¤¿ÆÇóµ÷¼Á
ÒѾÓÐ10È˻ظ´
283·ÖÇóµ÷¼Á
ÒѾÓÐ10È˻ظ´
295Çóµ÷¼Á
ÒѾÓÐ16È˻ظ´
0703»¯Ñ§
ÒѾÓÐ23È˻ظ´
283Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
wangkaibo123
ÈÙÓþ°æÖ÷ (Ö°Òµ×÷¼Ò)
kerry
-

ר¼Ò¾Ñé: +726 - PhEPI: 3
- Ó¦Öú: 1928 (½²Ê¦)
- ¹ó±ö: 0.598
- ½ð±Ò: 7869.1
- É¢½ð: 10156
- ºì»¨: 100
- Ìû×Ó: 3780
- ÔÚÏß: 1007.1Сʱ
- ³æºÅ: 2088618
- ×¢²á: 2012-10-26
- ÐÔ±ð: GG
- רҵ: ¿¹Ö×ÁöÒ©ÎïÒ©Àí
- ¹ÜϽ: ҩѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
|
²éѯģʽ£ºÄ£ºý²éѯ ̼Æ×Êý¾ÝÊäÈ룺 °´´ÓСµ½´ó˳ÐòÊäÈ룬Êý×Ö¼äÓÃÓ¢Îİë½Ç¶ººÅ(,)·Ö¸ôÀýÈ磺 21.4,30.4,37.4,73.2,73.7,125.6,126.6,139.6,140.2,168.2 ÈܼÁÑ¡Ï Æ¥ÅäÈݲ (Êý×Ö¸ñʽ£¬¿É×ÔÐÐÉ趨) ÏàËÆ¶È£º %(ÏàËÆ¶È>=50%) ²éѯ½á¹û£º¹²²éµ½22¸ö»¯ºÏÎï(²éѯ½á¹û½ö¹©²Î¿¼) 1 . tinidazole ÏàËÆ¶È:75% Magnetic Resonance in Chemistry 2005 43 139-146 Probing NMR parameters, structure and dynamics of 5-nitroimidazole derivatives. Density functional study of prototypical radiosensitizers Teodorico C. Ramalho and Michael B¨¹hl Structure 13C NMR ̼Æ×Ä£Äâͼ 2 . N-[2-(2-methyl-5-nitro-1H-imidazolyl)ethyl]-3-(2-nitro-1H-imidazolyl)propanesu]fonamide C9H15ClN4O4S ÏàËÆ¶È:75% Journal of Medicinal Chemistry 1995 38 1928-1941 Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny Structure 13C NMR ̼Æ×Ä£Äâͼ 3 . 2-(2-methyl-5-nitro-1H-imidazolyl)ethyl bromide ÏàËÆ¶È:71.4% Journal of Medicinal Chemistry 1995 38 1928-1941 Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny Structure 13C NMR ̼Æ×Ä£Äâͼ 4 . 1-(2-Bromoethyl)-2-methyl-5-nitro-1-imidazole ÏàËÆ¶È:57.1% Molecules 2009 14 1483-1494 Synthesis of Novel Hybrid Molecules from Precursors With Known Antiparasitic Activity Haythem A. Saadeh, Ibrahim M. Mosleh and Mohammad S. Mubarak Structure 13C NMR ̼Æ×Ä£Äâͼ 5 . N,N'-diisopropyl-2,6-bis(aminomethyl)pyridinium bromide C13H25N3Br2 ÏàËÆ¶È:57.1% Journal of Heterocyclic Chemistry 2006 43 549-557 Facile preparation and the crystal structure of N,N'-dialkyl-2,6-pyridinedimethanaminium halide Tohru Kobayashi,Tsuyoshi Yaita,Yumi Sugo,Hiroki Suda,Shinji Suzuki,Yuki Fujii and Yoshiharu Nakano Structure 13C NMR ̼Æ×Ä£Äâͼ 6 . metronidazole ÏàËÆ¶È:57.1% Magnetic Resonance in Chemistry 2005 43 139-146 Probing NMR parameters, structure and dynamics of 5-nitroimidazole derivatives. Density functional study of prototypical radiosensitizers Teodorico C. Ramalho and Michael B¨¹hl Structure 13C NMR ̼Æ×Ä£Äâͼ 7 . secnidazole ÏàËÆ¶È:57.1% Magnetic Resonance in Chemistry 2005 43 139-146 Probing NMR parameters, structure and dynamics of 5-nitroimidazole derivatives. Density functional study of prototypical radiosensitizers Teodorico C. Ramalho and Michael B¨¹hl Structure 13C NMR ̼Æ×Ä£Äâͼ 8 . 2-(2-methyl-5-nitro-1H-imidazolyl)ethyl iodide C6H8IN3O2 ÏàËÆ¶È:57.1% Journal of Medicinal Chemistry 1995 38 1928-1941 Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny Structure 13C NMR ̼Æ×Ä£Äâͼ 9 . N-methyl-2-(2-methyl-5-nitro-1H-imidazolyl)ethylamine C7H10Cl2N4O2 ÏàËÆ¶È:57.1% Journal of Medicinal Chemistry 1995 38 1928-1941 Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny Structure 13C NMR ̼Æ×Ä£Äâͼ 10 . 1,2-dimethyl-1H-phosphole ÏàËÆ¶È:57.1% Organic Magnetic Resonance 1973 5 161-162 Position specificity of 13C31P coupling constants for methyl substituents in phospholes and 2¡ªPhospholenes L. D. Quin, S. G. Borleske and R. C. Stocks Structure 13C NMR ̼Æ×Ä£Äâͼ 11 . 1-(3-nitro-1,2,4-1H-triazolyl)-3-(2-methyl-5-nitro-1H-imidazolyl)propan-2-ol C9H11N7O5 ÏàËÆ¶È:55.5% Journal of Medicinal Chemistry 1995 38 1928-1941 Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny Structure 13C NMR ̼Æ×Ä£Äâͼ 12 . N-[2-(2-methyl-5-nitro-1H-imidazolyl)ethyl]-3-propanesultam C9H14N4O4S ÏàËÆ¶È:55.5% Journal of Medicinal Chemistry 1995 38 1928-1941 Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny Structure 13C NMR ̼Æ×Ä£Äâͼ 13 . N-[2-(2-methyl-5-nitroimidazol-1H-yl)-ethyl]-N-methyltrifluoroacetamide C9H11F3N4O3 ÏàËÆ¶È:55.5% Journal of Medicinal Chemistry 1995 38 1928-1941 Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny Structure 13C NMR ̼Æ×Ä£Äâͼ 14 . compound 11 C8H14O ÏàËÆ¶È:50% Tetrahedron Letters 2003 44 7541-7544 Formation of (E) 1-alkoxy-1,3-butadienes from corresponding propargyl ethers; vicarious nucleophilic substitution in alkoxyallenes Robert Łysek, Ewa Woźny, Tong Thanh Danh, Marek Chmielewski Structure 13C NMR ̼Æ×Ä£Äâͼ |

2Â¥2013-12-12 22:04:39
lifeliuyan
ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
- PhEPI: 1
- Ó¦Öú: 3913 (¸±½ÌÊÚ)
- ½ð±Ò: 48805.6
- É¢½ð: 890
- ºì»¨: 208
- Ìû×Ó: 4735
- ÔÚÏß: 635.4Сʱ
- ³æºÅ: 1141109
- ×¢²á: 2010-11-07
- ÐÔ±ð: MM
- רҵ: ÖÐҩҩЧÎïÖÊ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
haoyumomo: ½ð±Ò+10 2013-12-13 10:56:39
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
haoyumomo: ½ð±Ò+10 2013-12-13 10:56:39
|
²éѯ½á¹û£º¹²²éµ½22¸ö»¯ºÏÎï(²éѯ½á¹û½ö¹©²Î¿¼) 1 . tinidazole ÏàËÆ¶È:75% Magnetic Resonance in Chemistry 2005 43 139-146 Probing NMR parameters, structure and dynamics of 5-nitroimidazole derivatives. Density functional study of prototypical radiosensitizers Teodorico C. Ramalho and Michael B¨¹hl Structure 13C NMR ̼Æ×Ä£Äâͼ 2 . N-[2-(2-methyl-5-nitro-1H-imidazolyl)ethyl]-3-(2-nitro-1H-imidazolyl)propanesu]fonamide C9H15ClN4O4S ÏàËÆ¶È:75% Journal of Medicinal Chemistry 1995 38 1928-1941 Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny Structure 13C NMR ̼Æ×Ä£Äâͼ 3 . 2-(2-methyl-5-nitro-1H-imidazolyl)ethyl bromide ÏàËÆ¶È:71.4% Journal of Medicinal Chemistry 1995 38 1928-1941 Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny Structure 13C NMR ̼Æ×Ä£Äâͼ 4 . 1-(2-Bromoethyl)-2-methyl-5-nitro-1-imidazole ÏàËÆ¶È:57.1% Molecules 2009 14 1483-1494 Synthesis of Novel Hybrid Molecules from Precursors With Known Antiparasitic Activity Haythem A. Saadeh, Ibrahim M. Mosleh and Mohammad S. Mubarak Structure 13C NMR ̼Æ×Ä£Äâͼ 5 . N,N'-diisopropyl-2,6-bis(aminomethyl)pyridinium bromide C13H25N3Br2 ÏàËÆ¶È:57.1% Journal of Heterocyclic Chemistry 2006 43 549-557 Facile preparation and the crystal structure of N,N'-dialkyl-2,6-pyridinedimethanaminium halide Tohru Kobayashi,Tsuyoshi Yaita,Yumi Sugo,Hiroki Suda,Shinji Suzuki,Yuki Fujii and Yoshiharu Nakano Structure 13C NMR ̼Æ×Ä£Äâͼ 6 . metronidazole ÏàËÆ¶È:57.1% Magnetic Resonance in Chemistry 2005 43 139-146 Probing NMR parameters, structure and dynamics of 5-nitroimidazole derivatives. Density functional study of prototypical radiosensitizers Teodorico C. Ramalho and Michael B¨¹hl Structure 13C NMR ̼Æ×Ä£Äâͼ 7 . secnidazole ÏàËÆ¶È:57.1% Magnetic Resonance in Chemistry 2005 43 139-146 Probing NMR parameters, structure and dynamics of 5-nitroimidazole derivatives. Density functional study of prototypical radiosensitizers Teodorico C. Ramalho and Michael B¨¹hl Structure 13C NMR ̼Æ×Ä£Äâͼ 8 . 2-(2-methyl-5-nitro-1H-imidazolyl)ethyl iodide C6H8IN3O2 ÏàËÆ¶È:57.1% Journal of Medicinal Chemistry 1995 38 1928-1941 Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny Structure 13C NMR ̼Æ×Ä£Äâͼ 9 . N-methyl-2-(2-methyl-5-nitro-1H-imidazolyl)ethylamine C7H10Cl2N4O2 ÏàËÆ¶È:57.1% Journal of Medicinal Chemistry 1995 38 1928-1941 Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny Structure 13C NMR ̼Æ×Ä£Äâͼ 10 . 1,2-dimethyl-1H-phosphole ÏàËÆ¶È:57.1% Organic Magnetic Resonance 1973 5 161-162 Position specificity of 13C31P coupling constants for methyl substituents in phospholes and 2¡ªPhospholenes L. D. Quin, S. G. Borleske and R. C. Stocks Structure 13C NMR ̼Æ×Ä£Äâͼ 11 . 1-(3-nitro-1,2,4-1H-triazolyl)-3-(2-methyl-5-nitro-1H-imidazolyl)propan-2-ol C9H11N7O5 ÏàËÆ¶È:55.5% Journal of Medicinal Chemistry 1995 38 1928-1941 Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny Structure 13C NMR ̼Æ×Ä£Äâͼ 12 . N-[2-(2-methyl-5-nitro-1H-imidazolyl)ethyl]-3-propanesultam C9H14N4O4S ÏàËÆ¶È:55.5% Journal of Medicinal Chemistry 1995 38 1928-1941 Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny Structure 13C NMR ̼Æ×Ä£Äâͼ 13 . N-[2-(2-methyl-5-nitroimidazol-1H-yl)-ethyl]-N-methyltrifluoroacetamide C9H11F3N4O3 ÏàËÆ¶È:55.5% Journal of Medicinal Chemistry 1995 38 1928-1941 Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny Structure 13C NMR ̼Æ×Ä£Äâͼ 14 . compound 11 C8H14O ÏàËÆ¶È:50% Tetrahedron Letters 2003 44 7541-7544 Formation of (E) 1-alkoxy-1,3-butadienes from corresponding propargyl ethers; vicarious nucleophilic substitution in alkoxyallenes Robert Łysek, Ewa Woźny, Tong Thanh Danh, Marek Chmielewski Structure 13C NMR ̼Æ×Ä£Äâͼ 15 . (¡À)-methyl 2-hydroxy-2-azabicyclo[2.2.1]hept-5-ene-3-exo-carboxylate C8H11NO3 ÏàËÆ¶È:50% Tetrahedron 2012 68 1682-1687 1,3- versus 1,4-[¦Ð4+¦Ð2] Cycloadditions between methyl glyoxylate oxime and cyclopentadiene or cyclopentene Carlos A.D. Sousa, M. Lu¨ªsa C. Vale, Xerardo Garcia-Mera, Jos¨¦ E. Rodr¨ªguez-Borges Structure 13C NMR ̼Æ×Ä£Äâͼ 16 . N-methyl-1-[1-(2-(2-methyl-5-nitro-1H-imidazole-1-yl)ethyl)-1H-1,2,3-triazole-4-yl]methylamine ÏàËÆ¶È:50% Bioorganic & Medicinal Chemistry 2012 20 4040-4048 Influence of ligand denticity on the properties of novel 99mTc(I)¨Ccarbonyl complexes. Application to the development of radiopharmaceuticals for imaging hypoxic tissue Soledad Fern¨¢ndez, Javier Giglio, Ana M. Rey, Hugo Cerecetto Structure 13C NMR ̼Æ×Ä£Äâͼ 17 . O-ethyl 2-thenoylthiocarbamate C8H9NO2S2 ÏàËÆ¶È:50% Tetrahedron 2012 68 9384-9390 Three practical approaches for the synthesis of novel 4,7-dihetarylpyrazolo[1,5-a][1,3,5]triazines Henry Insuasty, Braulio Insuasty, Edison Castro, Jairo Quiroga, Rodrigo Abon¨ªa, Manuel Nogueras, Justo Cobo Structure 13C NMR ̼Æ×Ä£Äâͼ 18 . 1-(2-nitro-1H-imidazolyl)-3-(2-methyl-5-nitro-1H-imidazolyl)propan-2-ol C10H12N6O5 ÏàËÆ¶È:50% Journal of Medicinal Chemistry 1995 38 1928-1941 Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny Structure 13C NMR ̼Æ×Ä£Äâͼ 19 . N-[2-(2-methyl-5-nitro-1H-imidazolyl)ethyl]trifluoroacetamide C8H9F3N4O3 ÏàËÆ¶È:50% Journal of Medicinal Chemistry 1995 38 1928-1941 Hypoxia-Selective Antitumor Agents. 10. Bis(nitroimidazoles) and Related Bis(nitroheterocycles): Development of Derivatives with Higher Rates of Metabolic Activation under Hypoxia and Improved Aqueous Solubility Michael P. Hay, Ho H. Lee, William R. Wilson, Peter B. Roberts, William A. Denny Structure 13C NMR ̼Æ×Ä£Äâͼ 20 . 5-ethyl-4-methyl-3-hydroxypyridine C8H11NO ÏàËÆ¶È:50% Chemical Research in Toxicology 2003 16 232-241 Model Studies on the Modification of Proteins by Lipoxidation-Derived 2-Hydroxyaldehydes Zhongfa Liu and Lawrence M. Sayre Structure 13C NMR ̼Æ×Ä£Äâͼ |
3Â¥2013-12-12 22:05:06














»Ø¸´´ËÂ¥